NEW LAW ALLOWS MEDICAL CANNABIS IN GIBRALTAR FOR THESE FOUR CONDITIONS
Gibraltar Health Authority (GHA) doctors will be allowed to hand out ‘cannabis-based products’ once they have undertaken the appropriate training.
Medicinal cannabis: Island could ‘miss the boat’ on economic benefits
Martyn Perkins said views on industrial cultivation were “rapidly changing” and a delay could mean “missing the boat” in financial terms.
Georgia’s limited medical cannabis program stalled
Politicians contacted by the Atlanta Journal-Constitution gave no reason why no one has been appointed to the Georgia Access to Medical Cannabis Commission.
Medical Marijuana Research Shows Promise in Lessening Opioid Use & Abuse
The analysis focused on seven studies, five of which concluded medical marijuana may be associated with benefits such as: decreased opioid overdose rates, decreased opioid use, improved quality of life and improved pain control.
Cannabis oil brought dog back from brink of death – and now he’s loving life.
A pet owner who was faced with the heartbreaking decision of whether to put her beloved dog down after he was given just days to live says cannabis oil saved his life.
Mexico set to legalise recreational use of cannabis in days
Mexico‘s Senate will vote for a bill to fully legalise marijuana in the next few days, a key lawmaker told Reuters, marking a major step towards changing the country’s approach to the drug by removing it as a source of income for violent drug gangs.
‘This weed is so much better’: Cannabis legalization in B.C. at one year
Mike Babins and Maria Petrucci cleared grey-market cannabis from the shelves of their dispensary last year on the eve of federal legalization, uncertain what the new market would bring.
Bill Turnbull tries cannabis in bid to cure advanced prostate cancer
Bill Turnbull is experimenting with cannabis to try and cure his advanced prostate cancer.
Medical cannabis product approved for epilepsy
Much like investors who have pulled back from the highly anticipated IPOs of 2019, many buyers of cannabis stocks and ETFs may want to think again before they hold out for better times and suffer a series of additional downdrafts. Despite the industry’s long-term prospects, some analysts have been cutting forecasts for cannabis sales and cash flow, expecting the underperformance to continue into next year.
Cannabis ETFs and Stocks May Be Next Shoe to Drop After Failed IPOs
Much like investors who have pulled back from the highly anticipated IPOs of 2019, many buyers of cannabis stocks and ETFs may want to think again before they hold out for better times and suffer a series of additional downdrafts. Despite the industry’s long-term prospects, some analysts have been cutting forecasts for cannabis sales and cash flow, expecting the underperformance to continue into next year.